Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

ganglioneuroblastoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

ganglioneuroblastoma

MONDO:0005035

Also known as:ganglioneuroblastoma (disease)ganglioneuroblastoma (morphologic abnormality)ganglioneuroblastoma, malignant

Find Clinical TrialsTrials

Overview

A neuroblastic tumor characterized by the presence of neuroblastic cells, ganglion cells, and a stroma with Schwannian differentiation constituting more than fifty-percent of the tumor volume. There are two histologic subtypes identified: ganglioneuroblastoma, intermixed and ganglioneuroblastoma, nodular.

Clinical Trials17 registered · 7 recruiting

Diagnosis

Biomarker and diagnostic research for ganglioneuroblastoma has been reported in the published literature.

Prognosis

Estimated prevalence: <1 in 1,000,000 (VERY_RARE).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

17 clinical trials registered, 7 recruiting. Interventions under study include drug therapy, procedural interventions, biologic therapy, and other interventions. Pipeline includes 5 PHASE3, 3 PHASE2, 3 PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT06296732](https://clinicaltrials.gov/study/NCT06296732)

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:23 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:251877

GARD

Genetic and Rare Diseases Info Center

GARD:20719

Questions for Your Care Team

→Are any of the 17 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	27	43%
Testing and diagnosis research	13	21%
Laboratory research	8	13%
Disease patterns and progression	7	11%
Clinical study results	4	6%
Research summaries	3	5%
New treatment approaches	1	2%

ganglioneuroblastoma

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications